Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina
- PMID: 11273666
- DOI: 10.1006/exer.2000.0965
Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina
Abstract
The macula of the human retina contains extraordinarily high concentrations of lutein and zeaxanthin, xanthophyll carotenoids that appear to play an important role in protecting against age-related macular degeneration, the leading cause of blindness among the elderly. It is likely that the uptake and stabilization of these carotenoids is mediated by specific xanthophyll-binding proteins. In order to purify and characterize such a binding protein, a carotenoid-rich membrane fraction derived from human macula or peripheral retina was prepared by homogenization, differential centrifugation, and detergent solubilization. Further purification was carried out using ion-exchange chromatography and gel-filtration chromatography coupled with continuous photodiode-array monitoring for endogenously associated xanthophyll carotenoids. The most highly purified preparations contained two major protein bands at 25 and 55 kDa that consistently co-eluted with endogenous lutein and zeaxanthin. The visible absorbance spectrum of the binding protein preparation closely matches the spectral absorbance of the human macular pigment, and it is bathochromically shifted about 10 nm from the spectrum of lutein and zeaxanthin dissolved in organic solvents. Binding of exogenously added lutein and zeaxanthin is saturable and specific with an apparent Kd of approximately 1 microM. Canthaxanthin and beta-carotene exhibit no significant binding activity to solubilized retinal membrane proteins when assayed under identical conditions. Other potential mammalian xanthophyll-binding proteins such as albumin, tubulin, lactoglobulin and serum lipoproteins possess only weak non-specific binding affinity for carotenoids when assayed under the same stringent binding conditions. This investigation provides the first direct evidence for the existence of specific xanthophyll-binding protein(s) in the vertebrate retina and macula. The possible roles of xanthophyll-binding proteins in normal macular function and in the pathogenesis of age-related macular degeneration remain to be elucidated.
Similar articles
-
Purification and partial characterization of a lutein-binding protein from human retina.Biochemistry. 2009 Jun 9;48(22):4798-807. doi: 10.1021/bi9004478. Biochemistry. 2009. PMID: 19402606
-
Retinal tubulin binds macular carotenoids.Invest Ophthalmol Vis Sci. 1997 Jan;38(1):167-75. Invest Ophthalmol Vis Sci. 1997. PMID: 9008641
-
Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration.Surv Ophthalmol. 2008 Jan-Feb;53(1):68-81. doi: 10.1016/j.survophthal.2007.10.008. Surv Ophthalmol. 2008. PMID: 18191658 Review.
-
Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina.Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1200-9. Invest Ophthalmol Vis Sci. 2000. PMID: 10752961
-
Resonance Raman measurement of macular carotenoids in the living human eye.Arch Biochem Biophys. 2004 Oct 15;430(2):163-9. doi: 10.1016/j.abb.2004.07.004. Arch Biochem Biophys. 2004. PMID: 15369814 Review.
Cited by
-
When is macular edema not macular edema? An update on macular telangiectasia type 2.Taiwan J Ophthalmol. 2015 Oct-Dec;5(4):149-155. doi: 10.1016/j.tjo.2015.09.001. Epub 2015 Nov 14. Taiwan J Ophthalmol. 2015. PMID: 29018690 Free PMC article. Review.
-
The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field.Am J Clin Nutr. 2012 Nov;96(5):1223S-33S. doi: 10.3945/ajcn.112.038240. Epub 2012 Oct 10. Am J Clin Nutr. 2012. PMID: 23053548 Free PMC article. Review.
-
Use of a 13C tracer to investigate lutein as a ligand for plasma transthyretin in humans.Lipids. 2005 Oct;40(10):1013-22. doi: 10.1007/s11745-005-1464-3. Lipids. 2005. PMID: 16382573 Clinical Trial.
-
Soluble lutein in combination with brilliant blue as a new dye for chromovitrectomy.Graefes Arch Clin Exp Ophthalmol. 2014 Jul;252(7):1071-8. doi: 10.1007/s00417-013-2539-5. Epub 2014 Jan 19. Graefes Arch Clin Exp Ophthalmol. 2014. PMID: 24441951 Clinical Trial.
-
Interactions between canthaxanthin and lipid membranes--possible mechanisms of canthaxanthin toxicity.Cell Mol Biol Lett. 2009;14(3):395-410. doi: 10.2478/s11658-009-0010-8. Epub 2009 Feb 12. Cell Mol Biol Lett. 2009. PMID: 19214394 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources